Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Change in Accured Expenses (2019 - 2026)

Summit Therapeutics filings provide 9 years of Change in Accured Expenses readings, the most recent being -$1.1 million for Q1 2026.

  • Quarterly Change in Accured Expenses fell 170.45% to -$1.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $163000.0 through Mar 2026, down 98.43% year-over-year, with the annual reading at $2.9 million for FY2025, 55.64% down from the prior year.
  • Change in Accured Expenses hit -$1.1 million in Q1 2026 for Summit Therapeutics, up from -$4.5 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $6.3 million in Q4 2024 and bottomed at -$5.6 million in Q3 2023.
  • Average Change in Accured Expenses over 5 years is $631529.4, with a median of $945000.0 recorded in 2025.
  • The largest annual shift saw Change in Accured Expenses tumbled 2598.58% in 2022 before it skyrocketed 15388.57% in 2023.
  • Summit Therapeutics' Change in Accured Expenses stood at -$35000.0 in 2022, then skyrocketed by 15388.57% to $5.4 million in 2023, then rose by 17.04% to $6.3 million in 2024, then crashed by 171.66% to -$4.5 million in 2025, then skyrocketed by 74.71% to -$1.1 million in 2026.
  • Per Business Quant, the three most recent readings for SMMT's Change in Accured Expenses are -$1.1 million (Q1 2026), -$4.5 million (Q4 2025), and $945000.0 (Q3 2025).